mTOR Inhibition and Hepatic Artery Thrombosis in de Novo Liver Transplant Recipients - Mitigation Strategy with Everolimus: 12 Month Results from Study H2304

2012 ◽  
Vol 94 (10S) ◽  
pp. 132
Author(s):  
S. Jonas ◽  
W. Chapman ◽  
L. McCormack ◽  
S. Gordon Burroughs ◽  
A. Alsina ◽  
...  
Keyword(s):  
Liver Transplant ◽  
Hepatic Artery ◽  
De Novo ◽  
Mitigation Strategy ◽  
Hepatic Artery Thrombosis ◽  
Transplant Recipients ◽  
Mtor Inhibition ◽  
Artery Thrombosis ◽  
Liver Transplant Recipients

Probability, management, and long-term outcomes of biliary complications after hepatic artery thrombosis in liver transplant recipients

Surgery ◽  
2017 ◽  
Vol 162 (5) ◽  
pp. 1101-1111 ◽  
Author(s):  
Masato Fujiki ◽  
Koji Hashimoto ◽  
Emmanouil Palaios ◽  
Cristiano Quintini ◽  
Federico N. Aucejo ◽  
...  
Keyword(s):  
Liver Transplant ◽  
Hepatic Artery ◽  
Biliary Complications ◽  
Hepatic Artery Thrombosis ◽  
Transplant Recipients ◽  
Long Term Outcomes ◽  
Artery Thrombosis ◽  
Liver Transplant Recipients

scholarly journals Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients

HPB ◽  
2016 ◽  
Vol 18 (3) ◽  
pp. 279-286 ◽  
Author(s):  
Jonathan G. Stine ◽  
Shawn J. Pelletier ◽  
Timothy M. Schmitt ◽  
Robert J. Porte ◽  
Patrick G. Northup
Keyword(s):  
Risk Factor ◽  
Portal Vein ◽  
Liver Transplant ◽  
Hepatic Artery ◽  
Independent Risk Factor ◽  
Graft Loss ◽  
Transplant Recipients ◽  
Vein Thrombosis ◽  
Artery Thrombosis ◽  
Liver Transplant Recipients
Sign in / Sign up

Export Citation Format

Share Document